Akero Therapeutics AKRO
$ 30.78
0.46%
Quarterly report 2024-Q3
added 11-08-2024
Akero Therapeutics Financial Statements 2011-2024 | AKRO
Annual Financial Statements Akero Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.44 B | 1.59 B | 617 M | 1 B | 375 M | - | - | - | - | - | - | - | - |
Shares |
52.6 M | 39 M | 34.8 M | 34 M | 15.1 M | - | - | - | - | - | - | - | - |
Historical Prices |
27.3 | 40.7 | 17.7 | 30.4 | 21.8 | - | - | - | - | - | - | - | - |
Net Income |
-152 M | -112 M | -101 M | -79.2 M | -43.8 M | -81.7 M | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-173 M | -115 M | -101 M | -80.2 M | -45.7 M | -13.8 M | - | - | - | - | - | - | - |
Interest Expense |
3.1 M | 739 K | - | - | 1.9 M | -67.9 M | - | - | - | - | - | - | - |
EBITDA |
-173 M | -115 M | -101 M | -80.1 M | -45.7 M | -13.8 M | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | 80.2 M | 45.7 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
31.1 M | 29.9 M | 19.1 M | 15.2 M | 8.6 M | 1.9 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Akero Therapeutics
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
69.4 M | 69.2 M | 55.8 M | 55.6 M | 51.9 M | 46.9 M | 46.9 M | 38.7 M | - | 35 M | 34.9 M | 34.9 M | 34.8 M | 34.7 M | 34.7 M | 34 M | 28.6 M | 28.5 M | 28.6 M | 28 M | 3.27 M | 168 K | 239 K | 127 K | 92.2 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-72.7 M | -56 M | - | -39.7 M | -31.1 M | -25.8 M | - | -35.5 M | -27.4 M | -26 M | - | -24.3 M | -28.9 M | -15.1 M | - | -79.2 M | -79.2 M | -79.2 M | - | -43.8 M | -43.8 M | -43.8 M | - | -11.1 M | -8.67 M | -421 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-81.7 M | -65.7 M | - | -46.6 M | -35.6 M | -28.8 M | - | -36.1 M | - | -26.1 M | - | -24.4 M | -29 M | -15.1 M | - | -21.5 M | -16.5 M | -12.4 M | - | -16.3 M | -7.61 M | -5.51 M | - | -1.73 M | -8.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
1.25 M | 1.23 M | - | 888 K | 857 K | 457 K | - | 324 K | - | - | - | - | - | - | - | 135 K | 247 K | 493 K | - | 755 K | 381 K | 150 K | - | -9.42 M | -11 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | -28.7 M | - | -36.1 M | - | -26 M | - | -24.3 M | -29 M | -15.1 M | - | -21.5 M | -16.5 M | -12.4 M | - | -16.3 M | -7.61 M | -5.51 M | - | -1.73 M | -8.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
9.47 M | 10.4 M | - | 7.98 M | 7.64 M | 6.97 M | - | 11 M | - | 5.54 M | - | 4.88 M | 4.99 M | 4.53 M | - | 4.16 M | 3.42 M | 3.59 M | - | 2.42 M | 1.65 M | 1.45 M | - | 474 K | 242 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency